ConductScience.org, home

Paper40940935

Conditionally Reprogrammed Cells as Preclinical Model for Rare Cancers.

Krawczyk E. Cancers (Basel), 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Conditionally Reprogrammed Cells as Preclinical Model for Rare Cancers. Papers, record 40940935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40940935

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Conditionally Reprogrammed Cells as Preclinical Model for Rare Cancers.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-25
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Krawczyk EEwahttps://orcid.org/0000-0002-1394-9720

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References168

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138541741Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges.Life (Basel)2024https://conductscience.org/library/papers/38541741PubMed
211413492Hayflick, his limit, and cellular ageing.Nat Rev Mol Cell Biol2000https://conductscience.org/library/papers/11413492PubMed
336477880Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methods.J Med Virol2023https://conductscience.org/library/papers/36477880PubMed
429721720Comparison of paired human nasal and bronchial airway epithelial cell responses to rhinovirus infection and IL-13 treatment.Clin Transl Med2018https://conductscience.org/library/papers/29721720PubMed
529973296Long-term expansion of primary equine keratinocytes that maintain the ability to differentiate into stratified epidermis.Stem Cell Res Ther2018https://conductscience.org/library/papers/29973296PubMed
636146860The First Human Vulvar Intraepithelial Neoplasia Cell Line with Naturally Infected Episomal HPV18 Genome.Viruses2022https://conductscience.org/library/papers/36146860PubMed
731623313CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis.Cancers (Basel)2019https://conductscience.org/library/papers/31623313PubMed
835305968Analysis of the diagnosis of Japanese patients with primary ciliary dyskinesia using a conditional reprogramming culture.Respir Investig2022https://conductscience.org/library/papers/35305968PubMed
929970881Δ133p53α, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells.Cell Death Dis2018https://conductscience.org/library/papers/29970881PubMed
1014519650Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.Clin Cancer Res2003https://conductscience.org/library/papers/14519650PubMed
1126283301Developing in vitro models of human ductal carcinoma in situ from primary tissue explants.Breast Cancer Res Treat2015https://conductscience.org/library/papers/26283301PubMed
1232064165Conditionally reprogrammed colorectal cancer cells combined with mouse avatars identify synergy between EGFR and MEK or CDK4/6 inhibitors.Am J Cancer Res2020https://conductscience.org/library/papers/32064165PubMed
1326536825Precision medicine for cancer with next-generation functional diagnostics.Nat Rev Cancer2015https://conductscience.org/library/papers/26536825PubMed
1431164413The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells.Mol Cancer Res2019https://conductscience.org/library/papers/31164413PubMed
1537376685Conditional Cell Reprogramming and Air-Liquid Interface Modeling Life Cycle of Oncogenic Viruses (HPV and EBV) in Epithelial Cells and Virus-Associated Human Carcinomas.Viruses2023https://conductscience.org/library/papers/37376685PubMed
1630420612Bcl-2-dependent synthetic lethal interaction of the IDF-11774 with the V0 subunit C of vacuolar ATPase (ATP6V0C) in colorectal cancer.Br J Cancer2018https://conductscience.org/library/papers/30420612PubMed
1729212548Generation of stable PDX derived cell lines using conditional reprogramming.Mol Cancer2017https://conductscience.org/library/papers/29212548PubMed
1825714835Multifactorial analysis of conditional reprogramming of human keratinocytes.PLoS One2015https://conductscience.org/library/papers/25714835PubMed
1922460905The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2012https://conductscience.org/library/papers/22460905PubMed
2035084050Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.Prostate2022https://conductscience.org/library/papers/35084050PubMed

See all 168 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40940935

GET https://conductscience.org/api/papers/v1/40940935/references?page=2